Marshall Wace, LLP Gh Research PLC Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Gh Research PLC stock. As of the latest transaction made, Marshall Wace, LLP holds 169,500 shares of GHRS stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,500Holding current value
$2.37 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GHRS
# of Institutions
51Shares Held
39.3MCall Options Held
12.2KPut Options Held
16.9K-
Bvf Inc San Francisco, CA8.83MShares$124 Million6.83% of portfolio
-
Lynx1 Capital Management LP San Juan, PR8.6MShares$120 Million23.88% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.68MShares$107 Million1.89% of portfolio
-
Rtw Investments, LP New York, NY5.57MShares$78 Million1.06% of portfolio
-
Cormorant Asset Management, LP Boston, MA1.92MShares$26.8 Million4.36% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $728M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...